Eugenol Market by Source Type, End Use and Application - Global Industry Analysis & Forecast to 2027

Published On : May 2022 Pages : 130 Category: Chemicals & Nanomaterials Report Code : CM053754

Eugenol Market By Source Type (Cinnamon, Basil, Cloves, Nutmeg and Others), End Use (Pharmaceutical Industry, Food Industry, Personal Care and Others) and Application (Stabilizers & Antioxidants, Essential Oils, Base Ingredient, Antiseptic & Anesthetic and Others) - Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

Eugenol is being seen as a powerful helpful device, which can be used in different nourishment items and home grown meds to fight significant metabolic clutters. Because of its noteworthy antimicrobial properties, eugenol looks for application in restraining development of the microbial populaces in a few nourishment items. Overwhelmingly looked for in flavors including cinnamon, basil, clove and nutmeg, eugenol contains intense neuron-defensive properties and anti stress. In light of these properties, eugenol holds capability of hindering transmission in sciatic nerves, and improving neuronal inconveniences.

Drivers and Restraints

Eugenol is viewed as a key bioactive atom, which is available is flavors and has hostile to diabetic potential. This has additionally come about into strong appropriation of eugenol and its subsidiaries in eating routine plans of diabetic patients, whose number is seeing a noteworthy flood around the world. The Eugenol Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.

Regional Insights

Asia-Pacific barring Japan is slated to stay overwhelming in the worldwide eugenol advertise. Strength of Japan in the market can be for the most part credited to flooding pervasiveness of diseases, for example, diabetes, and cancer.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • SouthAmerica
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Van Aroma
  • Sigma-Aldrich
  • Berjé, CV. Indaroma
  • Penta Manufacturing Company
  • Boc Sciences
  • Nile Chemicals
  • Nusaroma Indonesia Essential Oil
  • Extrasynthese
  • Vigon International

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Eugenol Market, By Source Type, Estimates and Forecast, 2017-2027 ($Million)

o    Cinnamon

o    Basil

o    Cloves

o    Nutmeg

o    Others

·         Eugenol Market, By End Use, Estimates and Forecast, 2017-2027 ($Million)

o    Pharmaceutical Industry

o    Food Industry

o    Personal Care

o    Others

·         Eugenol Market, By Application, Estimates and Forecast, 2017-2027 ($Million)

o    Stabilizers & Antioxidants

o    Essential Oils

o    Base Ingredient

o    Antiseptic & Anesthetic

o    Others

·         Eugenol Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)

o    Van Aroma

o    Sigma-Aldrich

o    Berjé, CV. Indaroma

o    Penta Manufacturing Company

o    Boc Sciences

o    Nile Chemicals

o    Nusaroma Indonesia Essential Oil

o    Extrasynthese

o    Vigon International

·         Eugenol Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o    North America

§  North America Eugenol Market, By Country

o    U.S. Eugenol Market

o    Canada Eugenol Market

o    Mexico Eugenol Market

o    Europe

§  Europe Eugenol Market, By Country

·         Germany Eugenol Market

o    UK Eugenol Market

o    France Eugenol Market

o    Russia Eugenol Market

o    Italy Eugenol Market

o    Rest of Europe Eugenol Market

o    Asia-Pacific

§  Asia-Pacific Eugenol Market, By Country

o    China Eugenol Market

o    Japan Eugenol Market

o    South Korea Eugenol Market

o    India Eugenol Market

o    Southeast Asia Eugenol Market

o    Rest of Asia-Pacific Eugenol Market

o    South America

§  South America Eugenol Market

o    Brazil Eugenol Market

o    Argentina Eugenol Market

o    Columbia Eugenol Market

o    Rest of South America Eugenol Market

o    Middle East and Africa

§  Middle East and Africa Eugenol Market

o    Saudi Arabia Eugenol Market

o    UAE Eugenol Market

o    Egypt Eugenol Market

o    Nigeria Eugenol Market

o    South Africa Eugenol Market

o    Rest of MEA Eugenol Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Eugenol Market, By Source Type

5.1.     Introduction

5.2.     Global Eugenol Revenue and Market Share by Source Type (2017-2027)

5.2.1.  Global Eugenol Revenue and Revenue Share by Source Type (2017-2027)

5.3.     Cinnamon

5.3.1.  Global Cinnamon Revenue and Growth Rate (2017-2027)

5.4.     Basil

5.4.1.  Global Basil Revenue and Growth Rate (2017-2027)

5.5.     Cloves

5.5.1.  Global Cloves Revenue and Growth Rate (2017-2027)

5.6.     Nutmeg

5.6.1.  Global Nutmeg  Revenue and Growth Rate (2017-2027)

5.7.     Others

5.7.1.  Global Others Revenue and Growth Rate (2017-2027)

6.       Eugenol Market, By End Use

6.1.     Introduction

6.2.     Global Eugenol Revenue and Market Share by End Use (2017-2027)

6.2.1.  Global Eugenol Revenue and Revenue Share by End Use (2017-2027)

6.3.     Pharmaceutical Industry

6.3.1.  Global Pharmaceutical Industry Revenue and Growth Rate (2017-2027)

6.4.     Food Industry

6.4.1.  Global Food Industry Revenue and Growth Rate (2017-2027)

6.5.     Personal Care

6.5.1.  Global Personal Care Revenue and Growth Rate (2017-2027)

6.6.     Others

6.6.1.  Global Others Revenue and Growth Rate (2017-2027)

7.       Eugenol Market, By Application

7.1.     Introduction

7.2.     Global Eugenol Revenue and Market Share by Application (2017-2027)

7.2.1.  Global Eugenol Revenue and Revenue Share by Application (2017-2027)

7.3.     Stabilizers and Antioxidants

7.3.1.  Global Stabilizers and Antioxidants Revenue and Growth Rate (2017-2027)

7.4.     Essential Oils

7.4.1.  Global Essential Oils Revenue and Growth Rate (2017-2027)

7.5.     Base Ingredient

7.5.1.  Global Base Ingredient Revenue and Growth Rate (2017-2027)

7.6.     Antiseptic and Anesthetic

7.6.1.  Global Antiseptic and Anesthetic Revenue and Growth Rate (2017-2027)

7.7.     Others

7.7.1.  Global Others Revenue and Growth Rate (2017-2027)

8.       Eugenol Market, By Region

8.1.     Introduction

8.2.     Global Eugenol Revenue and Market Share by Regions

8.2.1.  Global Eugenol Revenue by Regions (2017-2027)

8.3.     North America Eugenol by Countries

8.3.1.  North America Eugenol Revenue and Growth Rate (2017-2027)

8.3.2.  North America Eugenol Revenue (Million USD) by Countries (2017-2027)

8.3.3.  United States

8.3.3.1.  United States Eugenol Revenue (Millions USD) and Growth Rate (2017-2027)

8.3.4.  Canada

8.3.4.1.  Canada Eugenol Revenue (Millions USD) and Growth Rate (2017-2027)

8.3.5.  Mexico

8.3.5.1.  Mexico Eugenol Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.     Europe Eugenol by Countries

8.4.1.  Europe Eugenol Revenue and Growth Rate (2017-2027)

8.4.2.  Europe Eugenol Revenue (Million USD) by Countries (2017-2027)

8.4.3.  Germany

8.4.3.1.  Germany Eugenol Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.4.  France

8.4.4.1.  France Eugenol Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.5.  UK

8.4.5.1.  UK Eugenol Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.6.  Russia

8.4.6.1.  Russia Eugenol Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.7.  Italy

8.4.7.1.  Italy Eugenol Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.8.  Rest of Europe

8.4.8.1.  Rest of Europe Eugenol Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.     Asia-Pacific Eugenol by Countries

8.5.1.  Asia-Pacific Eugenol Revenue and Growth Rate (2017-2027)

8.5.2.  Asia-Pacific Eugenol Revenue (Million USD) by Countries (2017-2027)

8.5.3.  China

8.5.3.1.  China Eugenol Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.4.  Japan

8.5.4.1.  Japan Eugenol Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.5.  Korea

8.5.5.1.  Korea Eugenol Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.6.  India

8.5.6.1.  India Eugenol Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.7.  Southeast Asia

8.5.7.1.  Southeast Asia Eugenol Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.8.  Rest of Asia-Pacific

8.5.8.1.  Rest of Asia-Pacific Eugenol Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.     South America Eugenol by Countries

8.6.1.  South America Eugenol Revenue and Growth Rate (2017-2027)

8.6.2.  South America Eugenol Revenue (Million USD) by Countries (2017-2027)

8.6.3.  Brazil

8.6.3.1.  Brazil Eugenol Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.4.  Argentina

8.6.4.1.  Argentina Eugenol Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.5.  Columbia

8.6.5.1.  Columbia Eugenol Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.6.  Rest of South America

8.6.6.1.  Rest of South America Eugenol Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.     Middle East and Africa Eugenol by Countries

8.7.1.  Middle East and Africa Eugenol Revenue and Growth Rate (2017-2027)

8.7.2.  Middle East and Africa Eugenol Revenue (Million USD) by Countries (2017-2027)

8.7.3.  Saudi Arabia

8.7.3.1.  Saudi Arabia Eugenol Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.4.  United Arab Emirates

8.7.4.1.  United Arab Emirates Eugenol Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.5.  Egypt

8.7.5.1.  Egypt Eugenol Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.6.  Nigeria

8.7.6.1.  Nigeria Eugenol Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.7.  South Africa

8.7.7.1.  South Africa Eugenol Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.8.  Turkey

8.7.8.1.  Turkey Eugenol Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.9.  Rest of Middle East and Africa

8.7.9.1.  Rest of Middle East and Africa Eugenol Revenue (Millions USD) and Growth Rate (2017-2027)

9.       Company Profiles

9.1.     Van Aroma

9.1.1.  Business Overview

9.1.2.   Service Portfolio

9.1.3.  Strategic Developments

9.1.4.  Financial Overview

9.2.     Sigma-Aldrich

9.2.1.  Business Overview

9.2.2.   Service Portfolio

9.2.3.  Strategic Developments

9.2.4.  Financial Overview

9.3.     Berjé, CV. Indaroma

9.3.1.  Business Overview

9.3.2.   Service Portfolio

9.3.3.  Strategic Developments

9.3.4.  Financial Overview

9.4.     Penta Manufacturing Company

9.4.1.  Business Overview

9.4.2.   Service Portfolio

9.4.3.  Strategic Developments

9.4.4.  Financial Overview

9.5.     Boc Sciences

9.5.1.  Business Overview

9.5.2.   Service Portfolio

9.5.3.  Strategic Developments

9.5.4.  Financial Overview

9.6.     Nile Chemicals

9.6.1.  Business Overview

9.6.2.   Service Portfolio

9.6.3.  Strategic Developments

9.6.4.  Financial Overview

9.7.     Nusaroma Indonesia Essential Oil

9.7.1.  Business Overview

9.7.2.   Service Portfolio

9.7.3.  Strategic Developments

9.7.4.  Financial Overview

9.8.     Extrasynthese

9.8.1.  Business Overview

9.8.2.   Service Portfolio

9.8.3.  Strategic Developments

9.8.4.  Financial Overview

9.9.     Vigon International

9.9.1.  Business Overview

9.9.2.   Service Portfolio

9.9.3.  Strategic Developments

9.9.4.  Financial Overview

10.    Eugenol Market Forecast (2017-2027)

10.1. Global Eugenol Revenue (Millions USD) and Growth Rate (2017-2027)

10.2. Eugenol Market Forecast by Regions (2017-2027)

10.2.1.      North America Eugenol Market Forecast (2017-2027)

10.2.1.1. United States Eugenol Market Forecast (2017-2027)

10.2.1.2. Canada Eugenol Market Forecast (2017-2027)

10.2.1.3. Mexico Eugenol Market Forecast (2017-2027)

10.2.2.      Europe Eugenol Market Forecast (2017-2027)

10.2.2.1. Germany Eugenol Market Forecast (2017-2027)

10.2.2.2. France Eugenol Market Forecast (2017-2027)

10.2.2.3. UK Eugenol Market Forecast (2017-2027)

10.2.2.4. Russia Eugenol Market Forecast (2017-2027)

10.2.2.5. Italy Eugenol Market Forecast (2017-2027)

10.2.2.6. Rest of Europe Eugenol Market Forecast (2017-2027)

10.2.3.      Asia-Pacific Eugenol Market Forecast (2017-2027)

10.2.3.1. China Eugenol Market Forecast (2017-2027)

10.2.3.2. Japan Eugenol Market Forecast (2017-2027)

10.2.3.3. Korea Eugenol Market Forecast (2017-2027)

10.2.3.4. India Eugenol Market Forecast (2017-2027)

10.2.3.5. Southeast Asia Eugenol Market Forecast (2017-2027)

10.2.3.6. Rest of Asia-Pacific Eugenol Market Forecast (2017-2027)

10.2.4.      South America Eugenol Market Forecast (2017-2027)

10.2.4.1. Brazil Eugenol Market Forecast (2017-2027)

10.2.4.2. Argentina Eugenol Market Forecast (2017-2027)

10.2.4.3. Columbia Eugenol Market Forecast (2017-2027)

10.2.4.4. Rest of South America Eugenol Market Forecast (2017-2027)

10.2.5.      Middle East and Africa Eugenol Market Forecast (2017-2027)

10.2.5.1. Saudi Arabia Eugenol Market Forecast (2017-2027)

10.2.5.2. United Arab Emirates Eugenol Market Forecast (2017-2027)

10.2.5.3. Egypt Eugenol Market Forecast (2017-2027)

10.2.5.4. Nigeria Eugenol Market Forecast (2017-2027)

10.2.5.5. South Africa Eugenol Market Forecast (2017-2027)

10.2.5.6. Turkey Eugenol Market Forecast (2017-2027)

10.2.5.7. Rest of Middle East and Africa Eugenol Market Forecast (2017-2027)

10.3. Eugenol Market Forecast by Source Type (2017-2027)

10.3.1.      Eugenol Forecast by Source Type (2017-2027)

10.3.2.      Eugenol Market Share Forecast by Source Type (2017-2027)

10.4. Eugenol Market Forecast by End Use (2017-2027)

10.4.1.      Eugenol Forecast by End Use (2017-2027)

10.4.2.      Eugenol Market Share Forecast by End Use (2017-2027)

10.5. Eugenol Market Forecast by Application (2017-2027)

10.5.1.      Eugenol Forecast by Application (2017-2027)

10.5.2.      Eugenol Market Share Forecast by Application (2017-2027)


List of Tables

List of Tables and Figures:

Figure United States Eugenol Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Eugenol Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Eugenol Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Eugenol Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Eugenol Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Eugenol Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Eugenol Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Eugenol Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Eugenol Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Eugenol Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Eugenol Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Eugenol Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Eugenol Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Eugenol Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Eugenol Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Eugenol Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Eugenol Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Eugenol Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Eugenol Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Eugenol Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Eugenol Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Eugenol Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Eugenol Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Eugenol Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Eugenol Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Eugenol Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Eugenol Revenue and Revenue Share by Source Type (2017-2018)
Figure Global Cinnamon Revenue and Growth Rate (2017-2018)
Figure Global Basil Revenue and Growth Rate (2017-2018)
Figure Global Cloves Revenue and Growth Rate (2017-2018)
Figure Global Nutmeg Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Eugenol Revenue and Revenue Share by End Use (2017-2018)
Figure Global Pharmaceutical Industry Revenue and Growth Rate (2017-2018)
Figure Global Food Industry Revenue and Growth Rate (2017-2018)
Figure Global Personal Care Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Eugenol Revenue and Revenue Share by Application (2017-2018)
Figure Global Stabilizers and Antioxidants Revenue and Growth Rate (2017-2018)
Figure Global Essential Oils Revenue and Growth Rate (2017-2018)
Figure Global Base Ingredient Revenue and Growth Rate (2017-2018)
Figure Global Antiseptic and Anesthetic Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Eugenol Revenue by Regions (2017-2018)
Figure North America Eugenol Growth Rate (2017-2018)
Figure North America Eugenol Revenue and Growth Rate (2017-2018)
Figure North America Eugenol by Countries (2017-2018)
Figure North America Eugenol Revenue (Million USD) by Countries (2017-2018)
Figure United States Eugenol Growth Rate (2017-2018)
Figure United States Eugenol Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Eugenol Growth Rate (2017-2018)
Figure Canada Eugenol Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Eugenol Growth Rate (2017-2018)
Figure Mexico Eugenol Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Eugenol Growth Rate (2017-2018)
Figure Europe Eugenol Revenue and Growth Rate (2017-2018)
Figure Europe Eugenol by Countries (2017-2018)
Figure Europe Eugenol Revenue (Million USD) by Countries (2017-2018)
Figure Germany Eugenol Growth Rate (2017-2018)
Figure Germany Eugenol Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Eugenol Growth Rate (2017-2018)
Figure France Eugenol Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Eugenol Growth Rate (2017-2018)
Figure UK Eugenol Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Eugenol Growth Rate (2017-2018)
Figure Russia Eugenol Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Eugenol Growth Rate (2017-2018)
Figure Italy Eugenol Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Eugenol Growth Rate (2017-2018)
Figure Rest of Europe Eugenol Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Eugenol Growth Rate (2017-2018)
Figure Asia-Pacific Eugenol Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Eugenol by Countries (2017-2018)
Figure Asia-Pacific Eugenol Revenue (Million USD) by Countries (2017-2018)
Figure China Eugenol Growth Rate (2017-2018)
Figure China Eugenol Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Eugenol Growth Rate (2017-2018)
Figure Japan Eugenol Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Eugenol Growth Rate (2017-2018)
Figure Korea Eugenol Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Eugenol Growth Rate (2017-2018)
Figure India Eugenol Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Eugenol Growth Rate (2017-2018)
Figure Southeast Asia Eugenol Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Eugenol Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Eugenol Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Eugenol Growth Rate (2017-2018)
Figure South America Eugenol Revenue and Growth Rate (2017-2018)
Figure South America Eugenol by Countries (2017-2018)
Figure South America Eugenol Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Eugenol Growth Rate (2017-2018)
Figure Brazil Eugenol Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Eugenol Growth Rate (2017-2018)
Figure Argentina Eugenol Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Eugenol Growth Rate (2017-2018)
Figure Columbia Eugenol Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Eugenol Growth Rate (2017-2018)
Figure Rest of South America Eugenol Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Eugenol Growth Rate (2017-2018)
Figure Middle East and Africa Eugenol Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Eugenol by Countries (2017-2018)
Figure Middle East and Africa Eugenol Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Eugenol Growth Rate (2017-2018)
Figure Saudi Arabia Eugenol Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Eugenol Growth Rate (2017-2018)
Figure United Arab Emirates Eugenol Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Eugenol Growth Rate (2017-2018)
Figure Egypt Eugenol Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Eugenol Growth Rate (2017-2018)
Figure Nigeria Eugenol Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Eugenol Growth Rate (2017-2018)
Figure South Africa Eugenol Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Eugenol Growth Rate (2017-2018)
Figure Turkey Eugenol Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Eugenol Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Eugenol Revenue (Millions USD) and Growth Rate (2017-2018)
Table Van Aroma Eugenol Financial Overview
Table Sigma-Aldrich Eugenol Financial Overview
Table Berjé, CV. Indaroma Eugenol Financial Overview
Table Penta Manufacturing Company Eugenol Financial Overview
Table Boc Sciences Eugenol Financial Overview
Table Nile Chemicals Eugenol Financial Overview
Table Nusaroma Indonesia Essential Oil Eugenol Financial Overview
Table Extrasynthese Eugenol Financial Overview
Table Vigon International Eugenol Financial Overview
Figure Global Eugenol Revenue (Millions USD) and Growth Rate (2018-2025)
Table Eugenol Market Forecast by Regions (2018-2025)
Figure North America Eugenol Market Forecast (2018-2025)
Figure United States Eugenol Market Forecast (2018-2025)
Figure Canada Eugenol Market Forecast (2018-2025)
Figure Mexico Eugenol Market Forecast (2018-2025)
Figure Europe Eugenol Market Forecast (2018-2025)
Figure Germany Eugenol Market Forecast (2018-2025)
Figure France Eugenol Market Forecast (2018-2025)
Figure UK Eugenol Market Forecast (2018-2025)
Figure Russia Eugenol Market Forecast (2018-2025)
Figure Italy Eugenol Market Forecast (2018-2025)
Figure Rest of Europe Eugenol Market Forecast (2018-2025)
Figure Asia-Pacific Eugenol Market Forecast (2018-2025)
Figure China Eugenol Market Forecast (2018-2025)
Figure Japan Eugenol Market Forecast (2018-2025)
Figure Korea Eugenol Market Forecast (2018-2025)
Figure India Eugenol Market Forecast (2018-2025)
Figure Southeast Asia Eugenol Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Eugenol Market Forecast (2018-2025)
Figure South America Eugenol Market Forecast (2018-2025)
Figure Brazil Eugenol Market Forecast (2018-2025)
Figure Argentina Eugenol Market Forecast (2018-2025)
Figure Columbia Eugenol Market Forecast (2018-2025)
Figure Rest of South America Eugenol Market Forecast (2018-2025)
Figure Middle East and Africa Eugenol Market Forecast (2018-2025)
Figure Saudi Arabia Eugenol Market Forecast (2018-2025)
Figure United Arab Emirates Eugenol Market Forecast (2018-2025)
Figure Egypt Eugenol Market Forecast (2018-2025)
Figure Nigeria Eugenol Market Forecast (2018-2025)
Figure South Africa Eugenol Market Forecast (2018-2025)
Figure Turkey Eugenol Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Eugenol Market Forecast (2018-2025)
Figure Global Eugenol Forecast by Source Type (2018-2025)
Figure Global Eugenol Market Share Forecast by Source Type (2018-2025)
Figure Global Eugenol Forecast by Source Type (2018-2025)
Figure Global Eugenol Forecast by End Use (2018-2025)
Figure Global Eugenol Market Share Forecast by End Use (2018-2025)
Figure Global Eugenol Forecast by End Use (2018-2025)
Figure Global Eugenol Forecast by Application (2018-2025)
Figure Global Eugenol Market Share Forecast by Application (2018-2025)
Figure Global Eugenol Forecast by Application (2018-2025)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*